Longevity Fund 2 LP 4
4 · Decibel Therapeutics, Inc. · Filed Feb 18, 2021
Insider Transaction Report
Form 4
Longevity Fund 2 LP
10% Owner
Transactions
- Conversion
Common Stock
2021-02-17+79,143→ 79,143 total - Conversion
Convertible Series C Preferred Stock
2021-02-17−79,143→ 0 total→ Common Stock (79,143 underlying)
Footnotes (1)
- [F1]The Convertible Series C Preferred Stock converted into the issuer's common stock on a 12.6352-for-one basis upon the filing of the issuer's Restated Certificate of Incorporation in connection with the closing of the initial public offering and had no expiration date.